Various malignancies are resistant to Apo2L/TRAIL [126] and Oishi et al., investigated that apigenin increased the Apo2L/TRAIL-induced apoptosis in human pancreatic cancer cells (DU145 and LNCaP cell lines). The gene discussed is TNFSF10; the disease is pancreatic neoplasm.